Organic Cation Transporter 1 Inhibitors [MoA] - N0000191265

Name: Table of NDC products with organic cation transporter 1 inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000191265
Pharmacologic Name	Organic Cation Transporter 1 Inhibitors
Pharmacologic Uses	kinase inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Organic Cation Transporter 1 Inhibitors

The following table contains 2 products whose active ingredient are classified under the same pharmacologic class Organic Cation Transporter 1 Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	0069-8140	Xalkori	Non-Proprietary Name: Crizotinib	Capsule	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE
	0069-8141	Xalkori	Non-Proprietary Name: Crizotinib	Capsule	Oral	Pfizer Laboratories Div Pfizer Inc	ACTIVE